Publishing an AI Accountability Study in an SCI Q2 Journal
A completed law-related consultation that strengthened a comparative health-law study of AI-assisted clinical decisions, consent and professional accountability.
Anonymised composite:this case study illustrates our consultation process. Details are anonymised and combined from real engagements, and it should not be read as a verified individual client’s publication record. Our verified, named case studies are marked as such.
Where the client started
A health-law researcher had compared legal responsibility for clinicians using AI-assisted diagnostic tools across three jurisdictions — an important legal issue built on an unstable comparison.
The draft mixed binding legislation with non-binding guidance, relied on outdated summaries of proposed regulation, treated different healthcare systems as directly equivalent and moved from descriptive legal differences to broad claims about which jurisdiction offered the best patient protection.
What we did
Narrowed the study to how existing rules allocated duties of disclosure, clinical oversight and accountability when an AI recommendation influenced patient care. The paper distinguished current law from proposed reform, separated product liability from professional negligence and avoided presenting the analysis as individual legal advice.
Explained why the three legal systems were analytically comparable, identified the limits created by institutional differences, and prioritised legislation, reported judgments, regulator materials and authoritative guidance over commentary or media summaries.
Rechecked commencement dates, amendments, consultations and the status of proposed AI rules before finalising every claim, and applied the same questions on consent, standard of care, explainability, documentation and liability in each jurisdiction, marking recommendations as policy arguments rather than describing desirable reform as binding law.
Reorganised the manuscript around legal issues rather than country-by-country summaries. The researcher learned to state the authority supporting each proposition, explain when a rule remained unsettled and distinguish an AI tool's technical limitations from the legal duties of clinicians, manufacturers and healthcare institutions, with counterarguments included before proposing reform.
Assessed candidate journals for health law, medical technology, bioethics and interdisciplinary governance scope, methodological expectations, readership and publication cost. Web of Science coverage and quartile were checked at selection because classifications can change; the selected SCI Q2 outlet matched a legally rigorous analysis written for both legal and healthcare audiences.
Updated the authority table to identify source type, jurisdiction, legal status, effective date and the proposition supported; revised the consent analysis to distinguish disclosure of AI use from disclosure of material risks and reasonable alternatives; added a limitations section on unsettled case law, regulatory change and public–private healthcare differences; and checked citations, quotations, case names, legislative references, proofs and editorial queries before final publication approval.
The outcome
Following interdisciplinary peer review, revision and production checks, the article was published in an SCI-indexed Q2 health-law and medical-technology journal. The outcome reflects research and editorial consultation — not legal advice or a guarantee of publication.
The researcher gained a reusable method for selecting jurisdictions, ranking legal authorities, tracking regulatory change and separating current law from policy recommendations.
How we delivered this outcome
Could your research be the next case study?
Book a free consultation and we’ll map the fastest credible path from your manuscript to a published, indexed outcome.